Skip to content
Library/For Long/FOXO4-DRI
RUO · Research Use Only⚠ One-paper compound✓ Free to read

FOXO4-DRI

One mouse study, zero human trials, and a pitch to hunt down your worn-out 'zombie' cells and make them self-destruct.

Updated 03 May 2026Read 4 minBacked by 17 studies
The quick version
What it is
A peptide that tries to kill aged 'zombie' cells
Is it FDA-approved?
No. Sold for research only (RUO)
How strong is the proof?
Very weak. One mouse study, zero human studies
How you take it
A pulsed shot, not daily (mouse protocol only)
Typical result
Unknown in people. Mice grew back fur
Biggest catch
It is built to make cells die. Untested in humans

Any word with a dotted underline is a science word — tap it for a plain-English meaning.

In plain words.

FOXO4-DRI is an experimental . It is 29 amino acids long. It is built in a special backward, mirror-image way so your body cannot break it down fast.

Its job is to kill off old, broken-down cells. As you age, some cells stop working but refuse to die. People call them "zombie cells." The science word is senescent cells. They sit around and cause damage.

A that kills these cells is called a senolytic. FOXO4-DRI sneaks into a zombie cell and triggers it to self-destruct.

This is a lab idea, not a finished medicine. Almost everything known about it comes from one study.

What people use it for.

People interested in this are usually chasing anti-aging.

The hope is that clearing out old zombie cells could make tissue work better. In the famous mouse study, old mice on it grew back fur, moved better, and had healthier kidneys.

It is popular in the "live longer" crowd, like fans of Bryan Johnson. But all of that excitement rests on animals. No person has been tested in a proper trial.

Does it actually work?

We honestly do not know. There is no human proof.

The entire reputation comes from one study in 2017 (Baar and team, published in the journal Cell). They gave it to old mice, around 18 to 24 months old. The mice got healthier. That is a real and interesting result.

But that is it. Zero human trials. A few other mouse studies exist, and not all of them line up.

Killing your own cells on purpose is not a small risk like rubbing on a cream. Without human dose studies, taking this is a leap into the dark.

what you’ve probably heard.

The claims floating around online, and how true they actually are.

It clears out your zombie cells and rolls back aging.

unproven

That comes from one 2017 mouse study, where old mice grew fur back and had healthier kidneys. Zero people have taken it in a real trial, so in a human this is still a guess.

It only targets the bad senescent cells, so it's safe.

not quite

It was picky in mice. But the whole molecule is built to make cells self-destruct, and nobody has tested whether it stays that selective inside a person instead of a mouse.

Run it daily for a few weeks.

myth

The only protocol ever tested was 3 doses over 3 days in mice, then a long break. Daily dosing was never studied, so any 'daily plan' is invented.

The longevity crowd swears by it.

overblown

The enthusiasm is real, the evidence is not. Every claim still traces back to mice, and the mirror-image build is so hard to make that a basic lab test can't even confirm the vial holds the real thing.

How you take it.

There is no proven human dose. We can only tell you what the mouse study did.

The mice got it in pulses, not every day. The published protocol was 3 doses over 3 days, then a long break. So anyone selling a "daily" plan is making it up. Daily dosing was never tested.

People report a flu-like reaction for 1 to 3 days after a dose. There is no human data to explain that or to guide timing.

Honestly, there is no safe at-home recipe here. The numbers do not exist yet.

What to watch out for.

The serious stuff

This is designed to make cells die. That is the whole point. In mice it was picky about which cells. We do not know if it stays that picky in a human body.

  • Do not touch this if you or a close family member has had cancer. The way it works overlaps with how some cancer drugs work, and the interaction in people is unknown.
  • Do not use it during chemo or radiation.
  • There is no published safety record in healthy adults. None.

If you get any sudden symptoms after a dose, treat that as a reason to stop. And talk to a real doctor. We are not your doctor.

Where people get it.

Here are the ways people find it, safest to riskiest.

  • Brand. Does not exist. There is no version and no company running real trials.
  • . Very few pharmacies will touch it. Making a cell-killing before any human trial is a legal and ethical mess. Where sold, it runs $400–$800 a month.
  • Research-only (). This is most of the market. About $150–$400 a month. The catch: this is hard to make correctly. Many batches are not pure.
  • overseas. Cheapest, around $38 a month. Checking that the molecule is even built right is nearly impossible at this level.

A big red flag for all of it: the special mirror-image build is tricky, so a basic lab test cannot fully confirm you got the real thing.

Our honest take.

A wild idea sitting on almost no proof
The pitch is genuinely interesting: a that finds your worn-out "zombie" cells and triggers them to self-destruct. In one batch of old mice, it grew their fur back and cleaned up their kidneys. That single 2017 mouse paper is the entire story.

Zero people have taken this in a real trial. So if you inject it, you are the trial. And the part that sets it apart from a longshot supplement: the molecule is built to make cells die, and nobody knows how picky it stays once it is inside a human instead of a mouse.

If this corner of aging science pulls at you, the smarter watch is the senolytic ideas already being tested in actual people, like dasatinib plus quercetin, or fisetin. Read those before you put a mouse experiment in your own arm.

The studies behind this.

We read the research so you don't have to. Here's where the facts on this page come from.

  1. 01Born E, et al. Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression. Circulation. 2023;147(8):650-666. PMID: 36515093.
  2. 02Liu Y, et al. FOXO4-D-Retro-Inverso targets extracellular matrix production in fibroblasts and ameliorates bleomycin-induced pulmonary fibrosis in mice. Naunyn-Schmiedeberg's archives of pharmacology. 2023;396(10):2393-2403. PMID: 37074394.
  3. 03Meng J, et al. Targeting senescence-like fibroblasts radiosensitizes non-small cell lung cancer and reduces radiation-induced pulmonary fibrosis. JCI insight. 2021;6(23). PMID: 34877934.
  4. 04Bourgeois B, et al. The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI. Nature communications. 2025;16(1):5672. PMID: 40593617.
  5. 05Kong YX, et al. FOXO4-DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53-serine 15 phosphorylation. Communications biology. 2025;8(1):299. PMID: 39994346.
  6. 06Alameen AAM, et al. Targeting the FOXO4-p53 axis by retro-inverso peptide senolytic agents: a pharmacological strategy to mitigate brain aging and cognitive decline. Naunyn-Schmiedeberg's archives of pharmacology. 2026. PMID: 42024235.
  7. 07Li Y, et al. FOXO4-DRI improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells. Experimental gerontology. 2024;195:112522. PMID: 39025385.
  8. 08Zhang C, et al. FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice. Aging. 2020;12(2):1272-1284. PMID: 31959736.
  9. 09Hu Z, et al. FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway. Frontiers in bioengineering and biotechnology. 2026;13:1729166. PMID: 41625068.
  10. 10Huang Y, et al. Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes. Frontiers in bioengineering and biotechnology. 2021;9:677576. PMID: 33996787.
  11. 11Han X, et al. FOXO4 peptide targets myofibroblast ameliorates bleomycin-induced pulmonary fibrosis in mice through ECM-receptor interaction pathway. Journal of cellular and molecular medicine. 2022;26(11):3269-3280. PMID: 35510614.
  12. 12Valentijn FA, et al. Cellular senescence in the aging and diseased kidney. Journal of cell communication and signaling. 2018;12(1):69-82. PMID: 29260442.
  13. 13Jing X, et al. Cellular Senescence Contributes to the Progression of Hyperoxic Bronchopulmonary Dysplasia. American journal of respiratory cell and molecular biology. 2024;70(2):94-109. PMID: 37874230.
  14. 14van Willigenburg H, et al. Cellular senescence as a therapeutic target to improve renal transplantation outcome. Pharmacological research. 2018;130:322-330. PMID: 29471104.
  15. 15Krimpenfort P, et al. Rejuvenation by Therapeutic Elimination of Senescent Cells. Cell. 2017;169(1):3-5. PMID: 28340347.
  16. 16Liu BH, et al. [Molecular regulative mechanisms of aging and interventional effects of Chinese herbal medicine]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica. 2017;42(16):3065-3071. PMID: 29171222.
  17. 17Deryabin PI, et al. Targeting Multiple Homeostasis-Maintaining Systems by Ionophore Nigericin Is a Novel Approach for Senolysis. International journal of molecular sciences. 2022;23(22). PMID: 36430735.

We're not your doctor, and this isn't medical advice. It's a plain-English summary of what the research says, so you can have a smarter conversation with someone who is.

Keep up with this stuff

Want the rest of the peptide world, in plain English?

New breakdowns, safety updates, and what's actually worth your money. Free. Unsubscribe in one click.